Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – When statins alone can’t reverse dyslipidemia, the thyroid hormone analogue eprotirome may be helpful, new research suggests. In a 12-week study of 189…
NEW YORK (Reuters Health) – Four out of five children with juvenile idiopathic arthritis had a good clinical response to abatacept during a long-term open-label extension trial. The…
NEW YORK (Reuters Health) – Statin use by women cuts their risk of primary cardiovascular disease (CVD) events by roughly a third, which is similar to the risk…
NEW YORK (Reuters Health) – Three years after ST-segment elevation myocardial infarction (STEMI), sirolimus-eluting stents still provide better protection against major adverse cardiovascular events compared to bare metal…
NEW YORK (Reuters Health) – Patients report higher quality of life with continuous intraperitoneal versus subcutaneous insulin, Dutch investigators have found. The researchers had previously reported that continuous…
NEW YORK (Reuters Health) – Tenofovir nephrotoxicity can’t always be fully reversed in HIV-infected men, according to a new study. Up to 2% of patients have adverse renal…
NEW YORK (Reuters Health) – Ethosuximide and valproic acid are more effective than lamotrigine for treating childhood absence epilepsy, the most common pediatric epilepsy syndrome, according to a…
NEW YORK (Reuters Health) – Asymptomatic patients with a low ankle brachial index don’t seem to get cardiovascular protection from aspirin, randomized trial results suggest. The subjects came…
NEW YORK (Reuters Health) – In treating social anxiety disorder, phenelzine combined with cognitive behavioral group therapy achieves a higher response rates than either treatment alone or placebo,…
NEW YORK (Reuters Health) – Montelukast (Singulair), a leukotriene receptor antagonist, can help prevent recurrent wheezing episodes after respiratory syncytial virus (RSV) bronchiolitis, new research shows. From earlier…
